These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23550205)

  • 21. Efficacy of two-time prophylactic intravenous administration of tazobactam/piperacillin for transrectal ultrasound-guided needle biopsy of the prostate.
    Iwamoto H; Shigehara K; Miyagi T; Nakashima T; Shimamura M; Namiki M
    Prostate Int; 2015 Sep; 3(3):103-6. PubMed ID: 26473153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and microbiological determinants of infection after transrectal prostate biopsy.
    Liss MA; Johnson JR; Porter SB; Johnston B; Clabots C; Gillis K; Nseyo U; Holden M; Sakamoto K; Fierer J
    Clin Infect Dis; 2015 Apr; 60(7):979-87. PubMed ID: 25516194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
    Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
    J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Bacterial Prostatitis: Diagnosis and Management.
    Coker TJ; Dierfeldt DM
    Am Fam Physician; 2016 Jan; 93(2):114-20. PubMed ID: 26926407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
    Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
    J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
    Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
    J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prostate histopathology of NIH category IV prostatitis detected by sextant prostate needle biopsy from the patients with high prostatic specific antigen].
    Shimomura T; Kiyota H; Takahashi H; Madarame J; Kimura T; Onodera S
    Kansenshogaku Zasshi; 2003 Aug; 77(8):611-7. PubMed ID: 14515754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of Fluoroquinolone Resistant Aerobic Organisms and Efficacy of Rectal Cleaning in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy.
    Kongubol P; Santanirand P; Sirisreetreerux P; Viseshsindh W; Sangkum P
    J Med Assoc Thai; 2016 Jun; 99(6):691-6. PubMed ID: 29901317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen levels in acute and chronic bacterial prostatitis.
    Yamamoto M; Hibi H; Miyake K
    Hinyokika Kiyo; 1993 May; 39(5):445-9. PubMed ID: 7686714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis.
    Park MG; Cho MC; Cho SY; Lee JW
    Urol Int; 2016; 96(4):443-8. PubMed ID: 26943143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen.
    Potts JM
    J Urol; 2000 Nov; 164(5):1550-3. PubMed ID: 11025702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of acute bacterial prostatitis in elderly patients attended in the Emergency Department].
    Ferré Losa C; Llopis Roca F; Jacob Rodríguez J; Giol Amich J; Palom Rico X; Bardés Robles I
    Rev Esp Geriatr Gerontol; 2019; 54(3):143-146. PubMed ID: 30606500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone resistance and clinical characteristics of acute bacterial prostatitis in Japan: A multicenter study by the Japanese research group for urinary tract infection.
    Matsumoto M; Hamasuna R; Wada K; Sadahira T; Shigemura K; Maeda K; Hiyama Y; Togo Y; Nagasawa S; Yamanaka K; Shigehara K; Kobayashi K; Tsuchiya H; Miyazaki J; Nakagawa T; Ishikawa K; Takahashi S; Fujimoto N; Yamamoto S
    J Infect Chemother; 2024 Aug; ():. PubMed ID: 39151550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A significant percentage of patients with transrectal biopsy-related infections have positive blood cultures but negative urine cultures. A literature review and meta-analysis.
    Karakonstantis S; Kalemaki D
    Infect Dis (Lond); 2018; 50(11-12):791-803. PubMed ID: 30372643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S
    Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.